Share Name Share Symbol Market Type Share ISIN Share Description
Heiq Plc LSE:HEIQ London Ordinary Share GB00BN2CJ299 ORD GBP0.30
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 80.50 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
80.00 81.00 80.50 80.50 80.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 36.86 5.14 3.08 23.3 101
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 80.50 GBX

Heiq (HEIQ) Latest News

More Heiq News
Heiq Investors    Heiq Takeover Rumours

Heiq (HEIQ) Discussions and Chat

Heiq Forums and Chat

Date Time Title Posts
24/6/202212:59Heiq with all information4
06/6/202221:11Super Textile With Impressive Potential595

Add a New Thread

Heiq (HEIQ) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2022-06-30 15:37:1680.007,0005,600.00O
2022-06-30 14:53:4380.952,0001,619.00O
2022-06-30 09:56:3481.009,0027,291.62O
2022-06-30 09:55:4780.007,5086,006.40O
2022-06-30 09:51:1780.127,5006,009.00O
View all Heiq trades in real-time

Heiq (HEIQ) Top Chat Posts

Heiq Daily Update: Heiq Plc is listed in the Chemicals sector of the London Stock Exchange with ticker HEIQ. The last closing price for Heiq was 80.50p.
Heiq Plc has a 4 week average price of 80.50p and a 12 week average price of 75.50p.
The 1 year high share price is 157p while the 1 year low share price is currently 75.50p.
There are currently 125,891,904 shares in issue and the average daily traded volume is 97,789 shares. The market capitalisation of Heiq Plc is £101,342,982.72.
bad gateway: Missed the press conference. Decent piece on the website though and sounds quite a product for our new net zero world. CALL FOR EARLY ADOPTERS OF CELLULOSIC CLIMATE POSITIVE HEIQ AEONIQ YARN October 26, 2021 HeiQ announces a potential game-changer for the textile industry with the introduction of HeiQ AeoniQ – a high performance cellulose yarn based on a new fiber derived from carbon negative materials. This new fiber, which is derived from third generation cellulosic biopolymers, is advancing to pilot production prior to mass commercialization. The LYCRA Company is first to join HeiQ as a development partner. Whether it is cotton, wool or synthetic polymers, global textile production has a significant environmental impact with the industry responsible for more than 10% of global greenhouse gas emissions and over 20% of wastewater worldwide1. Conventional cellulosic fiber production uses arable land during growth and has limited design versatility, while raw materials for fossil-based synthetic materials are finite. Existing methods to recycle textile fabrics and garments made with all fibers are, for the most part, still not at scale and most fibers – whether synthetic or natural – take many years to degrade in landfills or oceans, leading to environmental build up. HeiQ AeoniQ cellulosic yarn made of climate positive raw materials HeiQ AeoniQ yarns (Aeon: striving for eternal circularity) are made out of cellulosic biopolymers that during growth bind carbon from the atmosphere while generating oxygen. This high-performance yarn is positioned to potentially substitute synthetic filament yarns which constitute over 60% of global annual textile output of 108 million metric tons 2. Further, when compared to conventional cellulosic products, HeiQ AeoniQ yarns do not draw on arable land, pesticides or fertilizer in their production. HeiQ AeoniQ yarns are designed for cradle-to-cradle circularity and can be recycled repeatedly while maintaining consistent fiber quality. The manufacturing process is expected to consume 99% less water than cotton yarns and HeiQ AeoniQ is designed to offer comparable performance properties to polyester, nylon and conventional regenerated cellulose yarns. Inviting first adopters HeiQ’s leading industry experts stand ready to deliver the first HeiQ AeoniQ yarns from the pilot production plant in Q2 2022. Given the outstanding qualities, the unique decarbonizing potential offered and outstanding ESG3 credentials, HeiQ is inviting a maximum of 20 sustainability-driven brand partners to be the first to market with products made of this game-changing future yarn. The LYCRA Company as a primary development partner HeiQ announces that The LYCRA Company, with its renowned collection of brands, global retail customer network and fabric innovation capabilities, will be a primary apparel development partner for HeiQ AeoniQ yarns with an exclusivity for stretch and performance fabrics. The LYCRA Company has a complete range of certified, sustainable products and is continuously complementing this range via the development of new types of LYCRA® fiber. These fibers have the potential to be combined with HeiQ AeoniQ yarn to create unique decarbonizing and degradable elastic fabrics. HeiQ Group Co-founder and CEO, Carlo Centonze states:“Climate change needs new inventions. By bringing HeiQ AeoniQ yarn to the textile industry, we will reduce our dependence on oil-based fibers, help decarbonize our planet and reduce the impact of the industry on climate change. Our yarn is a versatile alternative to polyester, nylon, and even conventional cellulosics and therefore has huge industry transformation potential. By wearing clothes made of HeiQ AeoniQ consumers can act in support of reducing C02 in our atmosphere. Adoption by billions of people offers potential to bind hundreds of millions of tons of CO2 from the atmosphere. A battle worth the fight.” The LYCRA Company CEO Julien Born notes: “With our future company strategy centering on sustainable solutions for the textile industry, we are proud to partner with HeiQ in both the technical development and commercialization of this fiber. The industry is ready for innovations such as HeiQ AeoniQ, and by combining our capabilities with those of HeiQ, we are truly well positioned to learn quickly and maximize the huge potential of this new technology.” Mr. Martin Gebert-Germ, a viscose filament yarn expert with 30 years of experience in the textile industry, stated, “This technology is the game changer for the whole textile industry.” Mr. Gebert-Germ, will join the newly-established HeiQ GmbH Austria as CEO and will be leading the HeiQ AeoniQ business from November 2021. The World Bank 2019 Statista Environment, Social, Governance hTTps://
bad gateway: Certainly better priced now. From HEIQ's site and picked up by Asprat on the lse. May or may not be price moving but seems another good idea from the co.. A yarn that capture co2? ANNOUNCING HEIQ PRESS CONFERENCE ON OCTOBER 26: “ETERNAL CIRCULARITY – CLIMATE POSITIVE CELLULOSIC HEIQ AEONIQ YARN TO REPLACE POLYESTER” October 19, 2021 Polyester and other synthetic fibers post huge sustainability challenges as they are a main source for microplastic pollution, lack biodegradability and have limited recyclability. But the growing world population and its demand for clothing cannot be matched by conventional cellulose fibers without use of scarce resources such as arable land and water. HeiQ is poised to launch HeiQ AeoniQ, a game-changing, climate positive yarn derived from sustainable cellulose materials that captures CO2 from the atmosphere, and is calling on forward-thinking, sustainability-driven brands to be the first to launch circular apparel and home textiles produced with HeiQ AeoniQ! This revolutionary yarn is designed for cradle-to-cradle circularity and can be recycled repeatedly while maintaining consistent fiber quality. It is wholly sourced from sustainable cellulosic raw materials, requires no arable land, pesticides or fertilizers, reduces water consumption during production by 99% compared to cotton, and has properties comparable to polyester, nylon and conventional cellulose yarns. Register for the press conference Profit from the opportunity to learn about HeiQ AeoniQ from experts. You will be able to ask questions during the Q&A part of the event. This press conference is mainly intended for members of the press, but interested brands are also welcome to join. The press conference takes place two times on October 26, 2021 (TUE) to allow people from different time zones to join: hTTps://
74tom: The problem I have with the current HEIQ valuation is that pre Covid they had a slow growth rate & were barely profitable. Viroblock sales gave 2021 profitability a one off boost which they took advantage of via an IPO in which shareholders sold some £40m of stock. Now we have a somewhat predictable flattening of revenue, increase in costs and lowering of gross margins and for the first time the share price is now lower than the 112p IPO. The question is what should HEIQ be valued at? I think this stock will be heavily sentiment driven, with successful innovations like Viroblock leading to lumpy revenue growth that will often be very difficult to predict. As confirmed in the investor meet company presentation this morning, the issues that caused the H1 miss are set to continue, with a 4th Covid wave in Asia a particular problem for them. I therefore expect HEIQ to fall below £1 over the coming weeks, likely coming to rest at somewhere near the £100m market cap level (77p). At this level I'd likely buy a starter position. I enjoyed listening to management answer investor questions, in particular when the CMO added additional colour around certain product launches & emphasised the question about why the share price had fallen so much, refreshing to hear compared to the wooden behaviour of some companies.
cottoner: HEIQ AND THE LYCRA COMPANY LAUNCH LYCRA® FRESHFX® BRAND WITH HEIQ TECHNOLOGY FOR THE CHINA MARKET September 22, 2021 WILMINGTON, Del.—September 22, 2021— Textile technology innovation leaders, HeiQ and The LYCRA Company, today announced they will be introducing LYCRA® freshFX® brand with HeiQ technology for the China market. “LYCRA® freshFX® brand with HeiQ technology is the first product resulting from a collaboration between The LYCRA Company and HeiQ that we announced in July,” said Steve Stewart, chief brand and innovation officer, The LYCRA Company. “The goal of this partnership is to combine our strengths to bring more market- relevant, innovative and sustainable textile technologies to consumers more quickly.” Garments made with LYCRA® freshFX® brand with HeiQ technology will offer consumers the renowned LYCRA® fiber benefits of lasting comfort, fit and shape, combined with HeiQ’s freshness and hygiene textile technologies. From odor absorption, antimicrobial to antiviral, with bio-based, mineral-based and silver-based technologies, HeiQ provides a comprehensive product range, now available with fabrics made with LYCRA® fiber. LYCRA® freshFX® brand with HeiQ technology can be used in activewear, athleisure apparel, personal protective equipment, socks, underwear, wovens, and non-apparel uses. The HeiQ finishes are applied directly to stretch fabrics made with LYCRA® fiber branded spandex. LYCRA® freshFX® brand with HeiQ technology can be customized to exact consumer needs via antiviral, antimicrobial, or anti-odor technology options. Fabrics featuring this technology are tested to ensure they meet the relevant national Guobiao (GB) standards for China as well as the established quality standards of both The LYCRA Company and HeiQ. Once certified, garments are eligible for identification at retail via physical or virtual hangtags. The all-day benefits of LYCRA® freshFX® brand with HeiQ technology will help consumers feel more comfortable and confident even after extended use. Garments with these freshness and hygiene innovations also have the potential to be laundered less, which would reduce water and energy consumption. “It has been exciting to team up with The LYCRA Company to bring our combined technologies to the China market first,” said Carlo Centonze, Co-founder and CEO of HeiQ Group. “The new generation of Chinese consumers are much more tech-savvy and looking for more comfort and functionality in their everyday clothes. LYCRA® freshFX® brand with HeiQ technology will deliver the functional benefits consumers desire today throughout a wide range of garment categories. I am really looking forward, together with The LYCRA Company, to bring new products to satisfy these growing consumer needs.” Both HeiQ and The LYCRA Company will be exhibiting at the upcoming Intertextile Shanghai. For product information and fabric samples, visit HeiQ (Booth C78) and The LYCRA Company (Booth E51) in Hall 1.1 at Intertextile Shanghai, October 9-11. For show information, visit hTtps://
cottoner: OUTDOOR RESEARCH LAUNCHES INSULATED RADIANTX GLOVES POWERED BY HEIQ XREFLEX TECHNOLOGY September 20, 2021 HeiQ XReflex technology for enhanced insulation with less bulk will make its first to market appearance in gloves from Outdoor Research. Zürich, Switzerland, 20 September 2021 – Outdoor Research, the Seattle-based leader in performance apparel and outdoor gear, launches its RadiantX Gloves and Mitts this fall, a new line of insulated handwear, making it the first brand to use revolutionary HeiQ XReflex Radiant Barrier Technology on gloves. The patented HeiQ XReflex Radiant Barrier technology was the finish of choice for the gloves and mitts as, unlike standard insulation systems, it provides enhanced warmth with less bulk and weight by reflecting radiant body heat to keep warmth in. The revolutionary technology utilizes ultra-thin surface coatings to reflect radiant body heat, improving thermal retention without reducing breathability. A perfect application of the technology is on gloves, where dexterity is crucial but can’t come at the expense of warmth. Pioneering New Technologies – Outdoor Research at the Forefront of Innovation Scheduled for launch in the USA, Canada and Internationally in Fall 2021, RadiantX Gloves and Mitts provide enhanced warmth when a slim profile is paramount to safety and agility. That means retaining function while handling cold objects like ice axes, pickets, and carabiners, and keeping fingers nimble and active with rope work, knots, rappelling and belaying. Four decades into glove and mitt manufacturing, Outdoor Research continues to strive for advancements in new technologies that change the way outdoor enthusiasts approach extreme environments. As the first company with HeiQ XReflex enhanced gloves, Outdoor Research found the perfect technology to address an age-old challenge: How to retain warmth in palms and fingers without sacrificing dexterity. “It was a no-brainer to partner with HeiQ on the HeiQ XReflex technology as it pairs both lightweight warmth and breathability — two qualities that you would want on any active cold weather glove” said Jenny Dashner, Outdoor Research Product Manager for Gloves. “The beauty of using it in the RadiantX glove is that we could place a thin, yet warm insulation in it without compromising the dexterity of the glove and mitt. Many ski and alpine athletes have told us that this is now their new favorite.” Carlo Centonze, Co-founder & CEO of HeiQ, said: “HeiQ XReflex is truly a revolutionary technology, especially for those who spend a lot of time in the outdoors, sometimes facing extreme weather conditions and cold. We couldn’t have found a better partner than Outdoor Research as the first company to implement this exceptional insulation for their high-performance gloves. Outdoor Research shares many philosophies with HeiQ so it’s not a surprise that many of their products are enhanced with HeiQ technologies. I wish all their mountaineering customers much success as they climb to new heights with warm and comfortable hands.” HeiQ XReflex Radiant Barrier Technology HeiQ XReflex, created by HeiQ’s joint-venture partner Xefco, is a patented radiant barrier technology that makes products thinner, lighter and warmer. HeiQ XReflex ultilizes an ultra-thin reflective surface coating that reflects energetic infrared body heat waves back to the body. The radiant barrier coating is applied to one side of the fabric via a high-tech vapor deposition process that doesn’t compromise the fabric’s air permeability, noise, touch, durable water repellence (DWR) or down proof properties. The radiant barrier textiles are combined together with optimized insulation materials to produce insulated assemblies with up to 50% less volume and weight while keeping the same level of warmth (measured in CLO). HeiQ XReflex is available on fabrics and non-woven scrims and lasts over 20 washes. Tom Hussey, CEO and Co-Founder, Xefco says: “We are so proud to see our technology used by Outdoor Research, their innovative mountaineering gloves are an ideal product for our ground-breaking radiant barrier technology. We wish their users a safe and satisfactory ascent.” hTtps://
earwacks: Not only that, some of the cheap brand face masks apparently are next to useless. Trouble is when the share price falls like this its hard to work out if the bigger trades are buys or sells. Initially it looked like share price was falling on small sells but more than normal UT trades too. I think will just have to weather this storm as not bing anything specific, but random trigger of analogue trading. June 9, 2021 KARMAN, a French supplier of healthcare and hygiene products, has joined forces with HeiQ, to launch the KARMAN ACTIV’PROTECT mask. This disposable Type IIR mask uses HeiQ’s patented HeiQ Viroblock textile technology. This technology gives the textiles of the KARMAN ACTIV’ PROTECT masks safe and permanent antimicrobial and antiviral properties, especially against SARS-CoV-2. June 22: LIFE’s 40+ products strengthen HeiQ’s global product offering and will facilitate HeiQ’s existing technology platforms into new markets, especially masterbatches, plastics and coatings. Leading manufacturers and brands, such as DuPont, American Standard, Igloo Products, Marks & Spencer, John Lewis, and Columbia Sportswear use LIFE’s antimicrobial additives. Through LIFE, HeiQ will also have access to hygiene technologies, such as odor absorbent additives, that complement HeiQ’s core antimicrobial technology. With the acquisition, HeiQ will now have additional offices and laboratories in Thailand and Brazil.
jammytass: pleased to announce that it has signed an Exclusive Licence and Chemicals Supply Agreement with ICP Industrial Inc, a division of ICP Group ("ICP"), the global leader in the development, application, and technical support of innovative thin film coatings which are applied to packaging used by the FMCG, pharmaceuticals and medical sectors. The two companies have signed a five year contract (US$8m in the first two years, at which point the contract is subject to renewal) which is expected to deliver US$30m of royalty revenue to the Company ("the Minimum Exclusive Requirement") in exchange for exclusive worldwide rights to apply HeiQ Viroblock to coatings for printing processes such as commercial print, food, beverage and pharma packaging. ICP will market its products with the HeiQ Viroblock technology and trademarks to its downstream customers, which manufacture packaging products for some of the world's largest consumer brands. This will enable brand owners to market products packaged in materials with antimicrobial properties to consumers. The two companies are currently completing the product development, due to be finalized at the latest by 1st August 2021, following which the exclusivity period begins. HeiQ will supply ICP with HeiQ Viroblock, an antimicrobial technology proven to destroy over 99.99% of infectious viruses and bacteria within minutes, and will receive a percentage of ICP's net sales in the form of royalties, in line with its strategy to grow its high margin royalty and licensing business. The partnership enables HeiQ to bring its market leading antimicrobials and other HeiQ technologies into several new industry fields served by ICP. HeiQ co-founder and CEO Carlo Centonze said: "This multi-year agreement with a global print and packaging coating leader builds on our recent contract to apply HeiQ Viroblock to paint, demonstrating that HeiQ Viroblock and antimicrobial technology is becoming mainstream for all materials that we touch in our daily lives. It is with great pleasure that we team up with ICP Industrial Inc, a global leader which provides the print and packaging industry with advanced coating technologies. It is of paramount importance given that the global pandemic has shown that viruses can remain infectious on paper and cardboard for several days. These recent agreements relating to HeiQ Viroblock being adopted by businesses outside of the textile industry also highlight that our award-winning innovation has entered a new phase in its lifecycle and that the brand equity we have built as an innovation leader is delivering meaningful returns. Subject to a successful trial period, we believe that this royalty arrangement has the potential to deliver strong, high margin sales for HeiQ and to strengthen our brand equity significantly, through uptake by ICP's blue chip client base." ICP Industrial's Division President Paul Grzebielucha said: "We are excited to offer this new innovative life-saving technology to the print world. We have global reach under our brands of Nicoat, MinusNine and Hitech Coatings to provide this protection on billions of printed surfaces per year. This HeiQ Viroblock game changing technology for our industry and society has proven to be a superior solution that is currently available in the marketplace. HeiQ products have proven efficacy in terms of destroying infectious viruses in minutes rather than hours with an effective rate of 99.95%. ICP Industrial has always provided innovative solutions to the graphic arts and packaging segments while maintaining the highest level of customer and technical service in the industry. ICP Industrial is very excited about the partnership with HeiQ bringing this technology to market pro
jammytass: RNS Berger paints Plc ("HeiQ" or "the Company") HeiQ Viroblock Partnership with Berger Paint HeiQ (LSE:HEIQ), an established global brand in materials and textile innovation which operates in high-growth markets, is pleased to announce that it has signed an agreement with global luxury paint provider Berger Paints India Ltd ("Berger"), among the largest 15 paint companies in the world. Berger will produce an innovative antiviral paint, Silk Breathe Easy, which will be powered by HeiQ Viroblock, proven to destroy over 99.99% of infectious viruses and bacteria. The agreement will deliver US$600,000 of revenue to HeiQ for the first year, during which Berger will have exclusivity in India, with potential for significant additional future revenues. The exclusivity term also has the potential to be extended by HeiQ. This partnership is in line with HeiQ's strategy to innovate in and beyond textiles, eventually becoming a global leader in materials innovation. This is the first time that HeiQ Viroblock, which won the prestigious Swiss Technology Award in 2020, will be used in the paints & coatings industry, opening up an exciting new market opportunity for HeiQ, which is dominated by Akzo Nobel, PPG and Sherwin Williams. Silk Breathe Easy is a luxury interior paint designed to give walls a rich appearance, to significantly reduce pollution and to protect by preventing surface transmission of diseases caused by bacteria and viruses. It is designed to enhance hygiene and reduce the risk of contamination in households, public and semi-public spaces. It can also be used in hygiene-sensitive environments such as surgical theaters and other medical and healthcare facilities. Formulated with 100% acrylic emulsions and vibrant pigments, it has low volatile organic compound ("VOC") and has formaldehyde reduction abilities. HeiQ co-founder and CEO Carlo Centonze said: "This contract demonstrates the significant market opportunity for HeiQ Viroblock beyond textiles, and with exclusivity only granted in India, there is potential to roll out the application of our award-winning antiviral technology in paint and coatings to different partners and territories. We are thrilled to have moved into this new US$150 billion material market alongside such a prestigious brand, which has built a strong industry reputation for being a first mover in establishing a number of trendsetting innovations. This builds on the success we have already experienced to date with our innovation, having already 'viroblocked' over a billion textile products since launching it a year ago.
jammytass: 3 March 2021 HeiQ Plc ( Acquisition of 51% of Industrial Biotech Business, Chrisal HeiQ Plc (LSE:HEIQ), an established global brand in materials and textile innovation which operates in high-growth markets, is pleased to announce that it has signed an agreement to acquire 51% of the share capital and voting rights of Chrisal N.V., Belgium ("Chrisal", "the Acquisition"). The Acquisition is for a consideration of €7.5 million, with €5.0 million payable in cash and €2.5 million through the issue of 1,101,928 new ordinary shares by HeiQ. On completion, Chrisal will be renamed HeiQ Chrisal. Chrisal is a profitable industrial biotechnology company and a leader in innovative ingredients and consumer products that incorporate the benefits of probiotics and synbiotics. It has 120 products within its three technology platforms that create healthy and sustainable microbial ecosystems. The application of its proprietary technology includes cosmetics, personal care, textiles, wound dressings, water purification, air treatment and cleaning products. Chrisal has recently developed a synbiotic interior cleaner, Synbio®, for healthcare and hospitals, a project sponsored by The Gates Foundation. Early results have indicated Synbio® cleaners to be equal to disinfectants and detergents but without bacterial resistance downsides, while offering enhanced cleaning performance. The Acquisition is aligned with HeiQ's strategy of becoming a global leader in materials innovation. It also solidifies HeiQ's position as a profitable and fast-growing pioneer in the $24 billion global textile chemicals market. HeiQ already directly serves the $10 billion antimicrobial textile market with its HeiQ Viroblock and HeiQ Pure technology platforms and the Acquisition will strengthen its presence with a complementary probiotic platform while enabling it to enter the new adjacent and lucrative markets of surface hygiene treatment, water purification and probiotic personal care. Additional Highlights · Chrisal recorded revenue of €5.5 million for the 12 months to 31 December 2020, an increase of 62% compared to 2019, and an operating profit of €1.6 million (28.9%) - unaudited. · Chrisal has over 500 commercial customers in 25 countries, including hospitals, food and cosmetic manufacturers, presenting HeiQ with compelling cross-selling opportunities for its existing core product range. Chrisal will benefit from HeiQ's extensive customer and distribution network, as well as its marketing prowess. · Chrisal customers include Q viva, Ahava, Atena-Alfa, Probilife, Sonax, Woellner and Greenspeed · The Acquisition includes a bottling facility in Belgium. This is an important infrastructure requirement for HeiQ's ambitions in functional textile aftercare and other fields. · The current Chrisal President and Founder Corrie Gielen and its CEO/CTO Dr. Robin Temmerman will continue to lead the business, supported by the existing Chrisal team. · HeiQ co-Founder and Group CEO Carlo Centonze as well as Group CFO Xaver Hangartner will join the HeiQ Chrisal Board of Directors and will explore further synergies over the course of 2021. · HeiQ Chrisal will be responsible for the creation, production and commercialisation of its products, with HeiQ acting as its corporate service hub and extended commercialization arm. · Chrisal's patented technology carries the prestigious EU Ecolabel, a label of excellence that is awarded solely to products meeting high environmental standards throughout their lifecycle. HeiQ co-founder and CEO Carlo Centonze said: "The acquisition of a majority stake in Chrisal brings multiple benefits to HeiQ and its shareholders. HeiQ Chrisal will provide us with revenue from other fast-growth markets adjacent to those we serve already, as well as exciting cross-selling opportunities for our and their existing core product range. The acquisition will progress our direct to consumer offer and enlarges our product offering to hygiene-sensitive environments, such as the healthcare sector. "Chrisal's technology platform includes an anti-allergen effect for mattresses and bedding, microbial and viral protection for surfaces, anti-inflammatory effects in wound dressings, probiotic skin enhancing cosmetics, algae and biofilm control in drinking water as well as advanced synbiotic protection to replace the resistance-creating antibiotics in animal husbandry. We are particularly excited about Chrisal's synbiotic technology solution for healthcare and hospitals for which full clinical results are due to be published imminently in a leading journal. "HeiQ is increasingly becoming more than a textile technology company; we are innovating materials more broadly. This acquisition of a leading probiotics business is aimed at making HeiQ a leader in probiotic innovation, positioning us well to serve many lucrative segments of this fast growth USD 50 billion market. "Chrisal's culture of entrepreneurship, people empowerment, sustainability, innovation and lean processes are a perfect match with HeiQ. I expect this partnership to become a great success and we will look forward to working closely with Corrie, Robin and the rest of the Chrisal team." Corrie Gielen, President of Chrisal commented: "For 30 years Chrisal has built on new technologies to improve our world in a sustainable way. With our latest patented Synbio® technology we have found the best solution to strengthen products, people and our environment. We are confident that the new partnership with HeiQ will bring us the additional competences and network needed to globalize this beautiful and groundbreaking technology. Together we combine the best of nature with the latest in science to make the difference for a better world." Further Information on Chrisal: Chrisal is an industrial biotechnology leader in prebiotic, probiotic and synbiotic technologies and products. With its 120 products, Chrisal serves commercial and consumer customers operating in the markets of cosmetics, personal care, textiles, wound dressings, water and air purification and cleaning solutions for hospitals and animal husbandry. Early results from clinical trials for Chrisal's patented Synbio®, an active synbiotic surface cleaner, suggest that it could be the next generation technology to probiotic surface cleaners, such as Reckitt Benckiser's VEO. Chrisal technology carries the prestigious EU Ecolabel, a label of environmental excellence that is awarded solely to products meeting high environmental standards throughout their lifecycle. The industrial biotech acquisition will provide HeiQ access to the technology platform of prebiotics, probiotics and postbiotics for bio-based odor & stain control for carpet & footwear, anti-allergen effect in mattress and bedding, microbial and viral protection for surfaces, anti-inflammatory effect in wound dressings, probiotic skin enhancing cosmetics, algae and biofilm control in drinking water as well as advanced synbiotic protection replacing the resistance-creating antibiotics in animal husbandry. With this strategic acquisition HeiQ enters the broader market of surface management and accesses a bio-based green complementary technology platform to its antimicrobials. Chrisal's 120 products strengthen HeiQ's global product offering and will facilitate HeiQ's existing technology platforms into new markets. Chrisal has a large, efficient manufacturing footprint in Lommel, Belgium and brings into the HeiQ group the strategic capability of bottling, a step required for HeiQ's B2C products ambitions in functional textile aftercare and other fields. Chrisal also includes a microbiology and molecular diagnostics lab for R&D and QC activities. HeiQ Chrisal, the new corporate name for Chrisal, will continue to be led by President and Founder Corrie Gielen, its CEO/CTO Dr. Robin Temmerman as well as the entire Chrisal team. The entrepreneurial drive will be strengthened by HeiQ's Group support functions in Rapid & Deep R&D, Branding & Marketing, Regulatory and Compliance as well as Commercialisation. HeiQ co-Founder and Group CEO Carlo Centonze as well as Group CFO Xaver Hangartner will join the HeiQ Chrisal Board of Directors. HeiQ Chrisal will be responsible for the creation, production and commercialization of its products, with the HeiQ Group acting as its corporate service hub and extended commercialization arm. Together, the newly enlarged Board will explore further synergies over the course of 2021. Issue of Equity and Total Voting Rights The Company will issue 1,101,928 new ordinary shares ("Consideration Shares") to the sellers of Chrisal, at a price of 1.9596p per share, which is the average 5 day closing price prior to signing, in order to part satisfy the consideration due. Applications will be made for the Consideration Shares to be admitted to the standard segment of the Official List, and to trading on the London Stock Exchange's Main Market ("Admission"). It is expected that Admission will become effective, and that dealings in the new Ordinary Shares are expected to commence, at 8.00 a.m. on 9 March 2021. Following Admission, the total number of Ordinary Shares in issue will be 126'993'832 and the total number of voting rights will therefore be 126'993'832. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules. This announcement contains inside information. For further information, please contact: HeiQ Plc
argy4: MASSIVE POTENTIAL: HeiQ Plc Concludes acquisition of majority stake in Spanish medical device manufacturer HeiQ Plc (LSE:HEIQ), an established global brand in materials and textile innovation which operates in high-growth markets, is pleased to announce that it has completed the acquisition of a majority stake in a leading Spanish mask manufacturer, MasFabEs, further to entering into a joint venture outlined in the Company's Prospectus. The manufacturer has been renamed HeiQ Medica S.L. and will manufacture medical devices with HeiQ's cutting-edge textile technologies. MasFabEs has already been producing OTC (over the counter) medical device Type IIR surgical masks (certified for use in a close clinical environments), enhanced with HeiQ Viroblock technology, since the beginning of the pandemic. To date, over 1 billion community face coverings as well as medical masks enhanced with HeiQ Viroblock technology have been sold and the technology is already being used by more than 150 major mask brands such as Burberry. The Company continues to experience strong demand for surgical masks which benefit from the extra protection provided by its Swiss Technology Award-winning HeiQ Viroblock technology. With a maximum production capacity of 15 million masks per month, enough to cover the needs of entire Switzerland with two masks a day, this acquisition will provide HeiQ with more control over the manufacture of its products. It will also provide the Company with an ideal base from which to establish an R&D hub for medical devices in Europe. Bulk order supply will be prioritised for institutions in the medical and healthcare sectors, such as hospitals, clinics, pharmacies and care homes. The masks will also be available on HeiQ's direct to consumer webshop. HeiQ co-founder and CEO Carlo Centonze said: "As a leading, profitable player in the $10 billion antimicrobial market, this manufacturing capability will ensure that we are well positioned to meet the strong on-going demand that we are experiencing for our products. The acquisition is in line with our stated strategy to deliver shareholder value by building on the significant momentum achieved by HeiQ Viroblock while also growing other innovations within our core product portfolio. The pandemic has changed our behaviour for good. Following the SARS epidemic in Asia in 2003, all medical and healthcare workers now use face masks daily in this region and we are confident that this practice will continue worldwide even when the Covid-19 pandemic is under control. "The third pillar of our growth strategy is focused on launching new high margin innovations which serve high growth markets. We are working on a range of exciting technologies, including a new antimicrobial technology with our long standing Australian partner Xefco, as well as our graphene membrane innovation. We look forward to sharing news of a number of exciting advancements ongoing within our R&D pipeline in the coming months." Pedro Herranz, Co-founder and General Manager of MasFabEs, said: "As a company that was founded expressly to provide "made in Spain" products, hence the name MasFabEs (Mascarillas de Fabricación Española), we were already producing HeiQ Viroblock powered masks and enjoyed an excellent relationship with HeiQ. Their majority participation, distribution reach and their plans for applying their materials innovations to medical devices were received with open arms and we are excited about future developments."
Heiq share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220701 07:17:30